Previous Close | 11.00 |
Open | 11.00 |
Bid | 16.30 |
Ask | 17.90 |
Strike | 140.00 |
Expire Date | 2024-12-20 |
Day's Range | 11.00 - 11.00 |
Contract Range | N/A |
Volume | |
Open Interest | 74 |
CAMBRIDGE, Mass., September 26, 2024--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will present at the 29th Annual Congress of the World Muscle Society 2024 Congress (WMS 2024), taking place Oct. 8-12, 2024, in Prague, Czechia.
The market is up 1.2% over the last week and has risen 30% over the past 12 months, with earnings forecast to grow by 15% annually. In this favorable environment, identifying high-growth tech stocks like TeraWulf can be crucial for investors looking to capitalize on robust market conditions and promising future earnings potential.
We recently published a list of 16 Best Mid Cap Growth Stocks To Buy Now. In this article, we are going to take a look at where Sarepta Therapeutics Inc. (NASDAQ:SRPT) stands against other best mid cap growth stocks. 50 Basis Point Reduction: Exaggeration or Hidden Benefit? Recent discussions among financial strategists emphasize the current […]